|Articles|February 15, 2020
- BioPharm International-02-15-2020
- Volume 2020 eBook
- Issue 1
Building Strategic Relationships with CROs
Author(s)Shreekant Karmarkar
How to adopt win-win strategies and understand quality agreements for complying with cGMP when building strategic relationships with pharmaceutical contract research organizations.
Advertisement
Pharmaceutical and biopharmaceutical companies have been extensively using contract research organizations (CROs) to meet their challenging needs in R&D and standard work for several decades. A noticeable shift occurred in outsourcing research and clinical work when Big Pharma R&D costs skyrocketed. For example, in 2012, approximately 33% of drugs in the pipelines of the top 10 pharmaceutical companies were initially developed elsewhere (1).
Article Details
BioPharm International
Outsourcing Resources eBook
February 2020
Pages: s20–s23
Citation
When referring to this article, please cite it as S. Karmarkar, “Building Strategic Relationships with CROs,” in BioPharm International Outsourcing Resources eBook (February 2020).
Articles in this issue
over 5 years ago
Biopharma Contract Market Updateover 5 years ago
Digitalization: A CDMO’s Perspectiveover 5 years ago
More Capacity and Technology Translate to More Optionsover 5 years ago
Sourcing Success in Cell and Gene Therapy Developmentover 5 years ago
Growth in Biologics Market Inspires OutsourcingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Orion and Abzena Collaboration Highlights Integrated Antibody Manufacturing Advances
2
BioPharm Weekly News Roundup—Week of Oct. 20, 2025
3
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
4
From Parm to Pharm: Avantor, p-Chip Bring COI Compliance to Clinical Consumables
5
